Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19574047rdf:typepubmed:Citationlld:pubmed
pubmed-article:19574047lifeskim:mentionsumls-concept:C0226896lld:lifeskim
pubmed-article:19574047lifeskim:mentionsumls-concept:C0205531lld:lifeskim
pubmed-article:19574047lifeskim:mentionsumls-concept:C0442027lld:lifeskim
pubmed-article:19574047lifeskim:mentionsumls-concept:C1527415lld:lifeskim
pubmed-article:19574047lifeskim:mentionsumls-concept:C0034242lld:lifeskim
pubmed-article:19574047lifeskim:mentionsumls-concept:C0257535lld:lifeskim
pubmed-article:19574047lifeskim:mentionsumls-concept:C1261322lld:lifeskim
pubmed-article:19574047lifeskim:mentionsumls-concept:C0038477lld:lifeskim
pubmed-article:19574047lifeskim:mentionsumls-concept:C0470187lld:lifeskim
pubmed-article:19574047lifeskim:mentionsumls-concept:C1708111lld:lifeskim
pubmed-article:19574047lifeskim:mentionsumls-concept:C0243077lld:lifeskim
pubmed-article:19574047pubmed:issue16lld:pubmed
pubmed-article:19574047pubmed:dateCreated2009-7-29lld:pubmed
pubmed-article:19574047pubmed:abstractTextA novel class of fused pyrazole-derived inhibitors of p38alpha mitogen-activated protein kinase (MAPK) is disclosed. These inhibitors were evaluated for their ability to inhibit the p38alpha enzyme, the secretion of TNFalpha in a LPS-challenged THP1 cell line and TNFalpha-induced production of IL-8 in 50% human whole blood. This series was optimized through a SAR investigation to provide inhibitors with IC(50) values in the low single-digit nanomolar range in whole blood. Further investigation of their pharmacokinetic profiles led to the identification of two potent and orally bioavailable p38 inhibitors 10 m and 10 q. Inhibitor 10 m was found to be efficacious in vivo in the inhibition of TNFalpha production in LPS-stimulated Lewis rats with an ED(50) of 0.1mg/kg while 10 q was found to have an ED(50) of 0.05-0.07 mg/kg.lld:pubmed
pubmed-article:19574047pubmed:languageenglld:pubmed
pubmed-article:19574047pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19574047pubmed:citationSubsetIMlld:pubmed
pubmed-article:19574047pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19574047pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19574047pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19574047pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19574047pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19574047pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19574047pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19574047pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19574047pubmed:statusMEDLINElld:pubmed
pubmed-article:19574047pubmed:monthAuglld:pubmed
pubmed-article:19574047pubmed:issn1464-3405lld:pubmed
pubmed-article:19574047pubmed:authorpubmed-author:HsiehFayeFlld:pubmed
pubmed-article:19574047pubmed:authorpubmed-author:McBrideHelenHlld:pubmed
pubmed-article:19574047pubmed:authorpubmed-author:WurzRyan PRPlld:pubmed
pubmed-article:19574047pubmed:authorpubmed-author:MohrChristoph...lld:pubmed
pubmed-article:19574047pubmed:authorpubmed-author:TaskerAndrew...lld:pubmed
pubmed-article:19574047pubmed:authorpubmed-author:XuShiminSlld:pubmed
pubmed-article:19574047pubmed:authorpubmed-author:LeeMatthew...lld:pubmed
pubmed-article:19574047pubmed:authorpubmed-author:SarisChristia...lld:pubmed
pubmed-article:19574047pubmed:authorpubmed-author:WongLu MinLMlld:pubmed
pubmed-article:19574047pubmed:authorpubmed-author:HenkleBradley...lld:pubmed
pubmed-article:19574047pubmed:authorpubmed-author:PlantMatthewMlld:pubmed
pubmed-article:19574047pubmed:authorpubmed-author:PettusLiping...lld:pubmed
pubmed-article:19574047pubmed:authorpubmed-author:ShermanLisaLlld:pubmed
pubmed-article:19574047pubmed:authorpubmed-author:MinerKentKlld:pubmed
pubmed-article:19574047pubmed:authorpubmed-author:ChmaitSamerSlld:pubmed
pubmed-article:19574047pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19574047pubmed:day15lld:pubmed
pubmed-article:19574047pubmed:volume19lld:pubmed
pubmed-article:19574047pubmed:ownerNLMlld:pubmed
pubmed-article:19574047pubmed:authorsCompleteYlld:pubmed
pubmed-article:19574047pubmed:pagination4724-8lld:pubmed
pubmed-article:19574047pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:19574047pubmed:meshHeadingpubmed-meshheading:19574047...lld:pubmed
pubmed-article:19574047pubmed:meshHeadingpubmed-meshheading:19574047...lld:pubmed
pubmed-article:19574047pubmed:meshHeadingpubmed-meshheading:19574047...lld:pubmed
pubmed-article:19574047pubmed:meshHeadingpubmed-meshheading:19574047...lld:pubmed
pubmed-article:19574047pubmed:meshHeadingpubmed-meshheading:19574047...lld:pubmed
pubmed-article:19574047pubmed:meshHeadingpubmed-meshheading:19574047...lld:pubmed
pubmed-article:19574047pubmed:meshHeadingpubmed-meshheading:19574047...lld:pubmed
pubmed-article:19574047pubmed:meshHeadingpubmed-meshheading:19574047...lld:pubmed
pubmed-article:19574047pubmed:meshHeadingpubmed-meshheading:19574047...lld:pubmed
pubmed-article:19574047pubmed:meshHeadingpubmed-meshheading:19574047...lld:pubmed
pubmed-article:19574047pubmed:meshHeadingpubmed-meshheading:19574047...lld:pubmed
pubmed-article:19574047pubmed:meshHeadingpubmed-meshheading:19574047...lld:pubmed
pubmed-article:19574047pubmed:meshHeadingpubmed-meshheading:19574047...lld:pubmed
pubmed-article:19574047pubmed:meshHeadingpubmed-meshheading:19574047...lld:pubmed
pubmed-article:19574047pubmed:meshHeadingpubmed-meshheading:19574047...lld:pubmed
pubmed-article:19574047pubmed:meshHeadingpubmed-meshheading:19574047...lld:pubmed
pubmed-article:19574047pubmed:meshHeadingpubmed-meshheading:19574047...lld:pubmed
pubmed-article:19574047pubmed:meshHeadingpubmed-meshheading:19574047...lld:pubmed
pubmed-article:19574047pubmed:meshHeadingpubmed-meshheading:19574047...lld:pubmed
pubmed-article:19574047pubmed:year2009lld:pubmed
pubmed-article:19574047pubmed:articleTitlePart 1: Structure-Activity Relationship (SAR) investigations of fused pyrazoles as potent, selective and orally available inhibitors of p38alpha mitogen-activated protein kinase.lld:pubmed
pubmed-article:19574047pubmed:affiliationDepartment of Chemistry Research & Discovery, Amgen Inc, Thousand Oaks, CA 91320, USA. rwurz@amgen.comlld:pubmed
pubmed-article:19574047pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:19574047lld:chembl